On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck's Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback